240 related articles for article (PubMed ID: 23708994)
41. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
[TBL] [Abstract][Full Text] [Related]
42. Hybrid tumour 'oncocytoma-chromophobe renal cell carcinoma' of the kidney: a report of seven sporadic cases.
Delongchamps NB; Galmiche L; Eiss D; Rouach Y; Vogt B; Timsit MO; Vieillefond A; Méjean A
BJU Int; 2009 May; 103(10):1381-4. PubMed ID: 19154497
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical stain for cytokeratin 7, S100A1 and claudin 8 is valuable in differential diagnosis of chromophobe renal cell carcinoma from renal oncocytoma.
Kim SS; Choi YD; Jin XM; Cho YM; Jang JJ; Juhng SW; Choi C
Histopathology; 2009 Apr; 54(5):633-5. PubMed ID: 19302533
[No Abstract] [Full Text] [Related]
44. Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases.
Adam J; Couturier J; Molinié V; Vieillefond A; Sibony M
Histopathology; 2011 Jun; 58(7):1064-71. PubMed ID: 21707708
[TBL] [Abstract][Full Text] [Related]
45. The Role of Genetic Analysis in Correct Diagnosis of Eosinophilic Variant of Chromophobe Renal Cell Carcinoma.
Molnar A; Yusenko MV; Kovacs G; Banyai D
Anticancer Res; 2020 Dec; 40(12):6863-6867. PubMed ID: 33288578
[TBL] [Abstract][Full Text] [Related]
46. Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis.
Wu H; Fan L; Liu H; Guan B; Hu B; Liu F; Hocher B; Yin L
Biomed Res Int; 2020; 2020():4030915. PubMed ID: 31998788
[TBL] [Abstract][Full Text] [Related]
47. Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
Ng KL; Ellis RJ; Samaratunga H; Morais C; Gobe GC; Wood ST
Transl Androl Urol; 2019 May; 8(Suppl 2):S123-S137. PubMed ID: 31236330
[TBL] [Abstract][Full Text] [Related]
48. Comparative study of CT appearances in renal oncocytoma and chromophobe renal cell carcinoma.
Wu J; Zhu Q; Zhu W; Chen W; Wang S
Acta Radiol; 2016 Apr; 57(4):500-6. PubMed ID: 25972369
[TBL] [Abstract][Full Text] [Related]
49. The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma.
Sun T; Hutchinson L; Zhou AG; Liu Q; Cosar EF; St Cyr M; Ninteau N; Dresser K; Cheng L; Jiang Z; Cornejo KM
Int J Surg Pathol; 2020 May; 28(3):259-264. PubMed ID: 31640438
[No Abstract] [Full Text] [Related]
50. Immunohistochemical analysis of cytochrome C oxidase facilitates differentiation between oncocytoma and chromophobe renal cell carcinoma.
Adam AC; Scriba A; Ortmann M; Huss S; Kahl P; Steiner S; Störkel S; Büttner R
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):54-9. PubMed ID: 25265428
[TBL] [Abstract][Full Text] [Related]
51. Nuclear morphometry as a tool of limited capacity for distinguishing renal oncocytoma from chromophobe carcinoma.
Okoń K; Sińczak-Kuta A
Pol J Pathol; 2008; 59(1):9-13. PubMed ID: 18655365
[TBL] [Abstract][Full Text] [Related]
52. Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma.
Xiao Y; Clima R; Busch J; Rabien A; Kilic E; Villegas SL; Timmermann B; Attimonelli M; Jung K; Meierhofer D
Cancer Res; 2020 Sep; 80(18):3830-3840. PubMed ID: 32694149
[TBL] [Abstract][Full Text] [Related]
53. Fine-needle aspiration biopsy of chromophobe renal cell carcinoma and oncocytoma: comparison of cytomorphologic features.
Wiatrowska BA; Zakowski MF
Cancer; 1999 Jun; 87(3):161-7. PubMed ID: 10385448
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemistry for the differential diagnosis of renal tumors with oncocytic features.
Fernández-Aceñero MJ; Cazorla A; Manzarbeitia F
Urol Oncol; 2011; 29(5):545-9. PubMed ID: 19926310
[TBL] [Abstract][Full Text] [Related]
55. Renal oncocytoma: a comparative clinicopathologic study and fluorescent in-situ hybridization analysis of 73 cases with long-term follow-up.
Dvorakova M; Dhir R; Bastacky SI; Cieply KM; Acquafondata MB; Sherer CR; Mercuri TL; Parwani AV
Diagn Pathol; 2010 May; 5():32. PubMed ID: 20497539
[TBL] [Abstract][Full Text] [Related]
56. Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas.
Meyer PN; Cao Y; Jacobson K; Krausz T; Flanigan RC; Picken MM
Diagn Mol Pathol; 2008 Sep; 17(3):141-4. PubMed ID: 18382368
[TBL] [Abstract][Full Text] [Related]
57. Cannabinoid CB1 receptor is expressed in chromophobe renal cell carcinoma and renal oncocytoma.
Larrinaga G; Sanz B; Blanco L; Perez I; Candenas ML; Pinto FM; Irazusta A; Gil J; López JI
Clin Biochem; 2013 May; 46(7-8):638-41. PubMed ID: 23318578
[TBL] [Abstract][Full Text] [Related]
58. Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors.
Kuroda N; Tanaka A; Yamaguchi T; Kasahara K; Naruse K; Yamada Y; Hatanaka K; Shinohara N; Nagashima Y; Mikami S; Oya M; Hamashima T; Michal M; Hes O
Med Mol Morphol; 2013 Mar; 46(1):49-55. PubMed ID: 23338778
[TBL] [Abstract][Full Text] [Related]
59. Expression of RON Proto-oncogene in Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Patton KT; Tretiakova MS; Yao JL; Papavero V; Huo L; Adley BP; Wu G; Huang J; Pins MR; Teh BT; Yang XJ
Am J Surg Pathol; 2004 Aug; 28(8):1045-50. PubMed ID: 15252311
[TBL] [Abstract][Full Text] [Related]
60. Renal oncocytosis: a clinicopathological and cytogenetic study of 42 tumours occurring in 11 patients.
Giunchi F; Fiorentino M; Vagnoni V; Capizzi E; Bertolo R; Porpiglia F; Vatrano S; Tamberi S; Schiavina R; Papotti M; Bollito E
Pathology; 2016 Jan; 48(1):41-6. PubMed ID: 27020208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
